{"count": 6, "results": [{"_id": "38408173", "pmid": 38408173, "title": "Association of metformin use with risk of newly onset neovascular age-related macular degeneration development.", "journal": "Retina", "authors": ["Khanna S", "Shaw L", "Hyman MJ", "Zhang J", "Hariprasad S", "Soo J", "Flores A", "Skondra D"], "date": "2023-10-30T00:00:00Z", "doi": "10.1097/IAE.0000000000003968", "meta_date_publication": "2023 Oct 30", "meta_volume": "", "meta_issue": "", "meta_pages": "", "score": 50269.227, "text_hl": "PURPOSE: To investigate if @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use reduces the odds of developing new @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@neovascular AMD@@@ (@<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@nAMD@@@). ", "citations": {"NLM": "Khanna S, Shaw L, Hyman MJ, Zhang J, Hariprasad S, Soo J, Flores A, Skondra D. Association of metformin use with risk of newly onset neovascular age-related macular degeneration development. Retina. 2023 Oct 30;():. PMID: 38408173", "BibTeX": "@article{38408173, title={Association of metformin use with risk of newly onset neovascular age-related macular degeneration development.}, author={Khanna S and Shaw L and Hyman MJ and Zhang J and Hariprasad S and Soo J and Flores A and Skondra D}, journal={Retina}}"}}, {"_id": "38259182", "pmid": 38259182, "title": "ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT.", "journal": "Retina", "authors": ["Khanna S", "Shaw L", "Hyman MJ", "Zhang J", "Hariprasad S", "Soo J", "Flores A", "Skondra D"], "date": "2024-02-01T00:00:00Z", "doi": "10.1097/IAE.0000000000003968", "meta_date_publication": "2024 Feb 1", "meta_volume": "44", "meta_issue": "2", "meta_pages": "205-213", "score": 50268.152, "text_hl": "PURPOSE: To investigate if @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ use reduces the odds of developing new @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@neovascular AMD@@@ (@<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@nAMD@@@). ", "citations": {"NLM": "Khanna S, Shaw L, Hyman MJ, Zhang J, Hariprasad S, Soo J, Flores A, Skondra D. ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT. Retina. 2024 Feb 1;44(2):205-213. PMID: 38259182", "BibTeX": "@article{38259182, title={ASSOCIATION OF METFORMIN USE WITH RISK OF NEWLY ONSET NEOVASCULAR AGE-RELATED MACULAR DEGENERATION DEVELOPMENT.}, author={Khanna S and Shaw L and Hyman MJ and Zhang J and Hariprasad S and Soo J and Flores A and Skondra D}, journal={Retina}, volume={44}, number={2}, pages={205-213}}"}}, {"_id": "39518910", "pmid": 39518910, "title": "Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.", "journal": "Int J Mol Sci", "authors": ["Xiao JF", "Luo W", "Mani A", "Barba H", "Solanki A", "Droho S", "Lavine JA", "Skondra D"], "date": "2024-10-22T00:00:00Z", "doi": "10.3390/ijms252111357", "meta_date_publication": "2024 Oct 22", "meta_volume": "25", "meta_issue": "21", "meta_pages": "", "score": 50251.41, "text_hl": "Current treatments relying on intravitreal (IVT) administration of anti-angiogenic agents are costly and of moderate effectiveness. @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@Metformin@@@, the common anti-@DISEASE_Diabetes_Mellitus @DISEASE_MESH:D003920 @@@diabetic@@@ drug, has been associated with decreased odds of developing @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@AMD@@@. ", "citations": {"NLM": "Xiao JF, Luo W, Mani A, Barba H, Solanki A, Droho S, Lavine JA, Skondra D. Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration. Int J Mol Sci. 2024 Oct 22;25(21):. PMID: 39518910", "BibTeX": "@article{39518910, title={Intravitreal Metformin Protects Against Choroidal Neovascularization and Light-Induced Retinal Degeneration.}, author={Xiao JF and Luo W and Mani A and Barba H and Solanki A and Droho S and Lavine JA and Skondra D}, journal={Int J Mol Sci}, volume={25}, number={21}}"}}, {"_id": "37440017", "pmid": 37440017, "title": "Repurposing Drugs for Treatment of Age-Related Macular Degeneration.", "journal": "Adv Exp Med Biol", "authors": ["Francisco SG", "Rowan S"], "date": "2023-01-01T00:00:00Z", "doi": "10.1007/978-3-031-27681-1_12", "meta_date_publication": "2023", "meta_volume": "1415", "meta_issue": "", "meta_pages": "73-77", "score": 50250.41, "text_hl": "A promising approach is repurposing of FDA-approved medications to treat @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@AMD@@@. Databases containing medical and drug records allow for retroactive identification of drugs whose use correlates with reduced @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@AMD@@@ diagnosis. ", "citations": {"NLM": "Francisco SG, Rowan S. Repurposing Drugs for Treatment of Age-Related Macular Degeneration. Adv Exp Med Biol. 2023;1415():73-77. PMID: 37440017", "BibTeX": "@article{37440017, title={Repurposing Drugs for Treatment of Age-Related Macular Degeneration.}, author={Francisco SG and Rowan S}, journal={Adv Exp Med Biol}, volume={1415}, pages={73-77}}"}}, {"_id": "30973575", "pmid": 30973575, "pmcid": "PMC6736343", "title": "The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration", "journal": "Invest Ophthalmol Vis Sci", "authors": ["Brown EE", "Ball JD", "Chen Z", "Khurshid GS", "Prosperi M", "Ash JD"], "date": "2019-04-01T00:00:00Z", "doi": "10.1167/iovs.18-26422", "meta_date_publication": "2019 Apr 1", "meta_volume": "60", "meta_issue": "5", "meta_pages": "1470-1477", "score": 50070.336, "text_hl": "@SPECIES_9606 @@@Patients@@@ who had taken @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ had decreased odds of developing @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@AMD@@@, suggesting that @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ may have a therapeutic role in @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@AMD@@@ development or progression in those who are at risk. ", "citations": {"NLM": "Brown EE, Ball JD, Chen Z, Khurshid GS, Prosperi M, Ash JD. The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration Invest Ophthalmol Vis Sci. 2019 Apr 1;60(5):1470-1477. PMID: 30973575", "BibTeX": "@article{30973575, title={The Common Antidiabetic Drug Metformin Reduces Odds of Developing Age-Related Macular Degeneration}, author={Brown EE and Ball JD and Chen Z and Khurshid GS and Prosperi M and Ash JD}, journal={Invest Ophthalmol Vis Sci}, volume={60}, number={5}, pages={1470-1477}}"}}, {"_id": "23898516", "pmid": 23898516, "title": "[Study on the anti-Lewis lung carcinoma effect of metformin combined with MCT1 inhibitor CHC].", "journal": "Sichuan Da Xue Xue Bao Yi Xue Ban", "authors": ["Guo FC", "Wang LQ", "Zhang J", "Wang YS"], "date": "2013-05-01T00:00:00Z", "meta_date_publication": "2013 May", "meta_volume": "44", "meta_issue": "3", "meta_pages": "375-8", "score": 50060.184, "text_hl": "METHODS: In vitro, the utilization of lactate acid was measured by @CHEMICAL_Lactic_Acid @CHEMICAL_MESH:D019344 @@@lactate@@@ assay in cultured medium and the inhibition of @CELLLINE_CVCL:C4DW @@@LL/2@@@ cell proliferation of four groups [control group, @<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ group (1 mmol/L and 5 mmol/L), @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@CHC@@@ group (5 mmol/L) and the combination group (@<m>CHEMICAL_Metformin</m> @CHEMICAL_MESH:D008687 @@@metformin@@@ 5 mmol/L and @<m>DISEASE_Glycogen_Storage_Disease_Type_II</m> @DISEASE_MESH:D006009 @@@CHC@@@ 5 mmol/L)] was detected in 24 h, 48 h, and their apoptosis in 24 h was also detected. ", "citations": {"NLM": "Guo FC, Wang LQ, Zhang J, Wang YS. [Study on the anti-Lewis lung carcinoma effect of metformin combined with MCT1 inhibitor CHC]. Sichuan Da Xue Xue Bao Yi Xue Ban. 2013 May;44(3):375-8. PMID: 23898516", "BibTeX": "@article{23898516, title={[Study on the anti-Lewis lung carcinoma effect of metformin combined with MCT1 inhibitor CHC].}, author={Guo FC and Wang LQ and Zhang J and Wang YS}, journal={Sichuan Da Xue Xue Bao Yi Xue Ban}, volume={44}, number={3}, pages={375-8}}"}}]}